Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Leto DL, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: findlater a. Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0162721. doi: 10.1128/AAC.01627-21. Epub 2021 Oct 18. Antimicrob Agents Chemother. 2022. PMID: 34662190 Free PMC article.
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review.
Bai AD, Komorowski AS, Lo CKL, Tandon P, Li XX, Mokashi V, Cvetkovic A, Findlater A, Liang L, Tomlinson G, Loeb M, Mertz D; McMaster Infectious Diseases Fellow Research Group. Bai AD, et al. Among authors: findlater a. BMC Med Res Methodol. 2021 Apr 19;21(1):75. doi: 10.1186/s12874-021-01260-7. BMC Med Res Methodol. 2021. PMID: 33874894 Free PMC article.
Confidence interval of risk difference by different statistical methods and its impact on the study conclusion in antibiotic non-inferiority trials.
Bai AD, Komorowski AS, Lo CKL, Tandon P, Li XX, Mokashi V, Cvetkovic A, Findlater A, Liang L, Tomlinson G, Loeb M, Mertz D; McMaster Infectious Diseases Fellow Research Group. Bai AD, et al. Among authors: findlater a. Trials. 2021 Oct 16;22(1):708. doi: 10.1186/s13063-021-05686-8. Trials. 2021. PMID: 34656155 Free PMC article.
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic review.
Komorowski AS, Bai AD, Cvetkovic A, Mourad O, Lo CKL, Li XX, Mokashi V, Findlater A, Duncan DB, Fuller C, Yamamura D, Mertz D; McMaster Infectious Diseases Fellow Research Group. Komorowski AS, et al. Among authors: findlater a. Clin Microbiol Infect. 2022 May;28(5):640-648. doi: 10.1016/j.cmi.2021.11.003. Epub 2021 Nov 8. Clin Microbiol Infect. 2022. PMID: 34763055 Free article. Review.
Infectious diseases, comorbidities and outcomes in hospitalized people who inject drugs (PWID).
Lim J, Pavalagantharajah S, Verschoor CP, Lentz E, Loeb M, Levine M, Smieja M, Mbuagbaw L, Kalina D, Tarride JE, O'Shea T, Cvetkovic A, van Gaalen S, Findlater AR, Lennox R, Bassim C, Lokker C, Alvarez E. Lim J, et al. Among authors: findlater ar. PLoS One. 2022 Apr 20;17(4):e0266663. doi: 10.1371/journal.pone.0266663. eCollection 2022. PLoS One. 2022. PMID: 35443003 Free PMC article.
25 results